Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study
Journal of Diabetes & Metabolic Disorders · 21.07.2026 · 25 (2)
DOI: 10.1007/s40200-026-02010-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 21.07.2026. Verfasst von Masoumeh Mahdi-Akhgar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
Cardiovascular diseases (CVD) are a leading cause of mortality in Iran and globally. This study aimed to provide more accurate estimates of associations between risk factors and CVD mortality by applying competing risk models within the Tehran Lipid and Glucose Study cohort.
Methods
In this prospective analysis, 7,529 individuals aged ≥ 30 years without prevalent CVD were followed for a median of 19.87 years. The primary outcome was CVD mortality ( n = 311), with non-CVD death as the competing event ( n = 592). Analyses were stratified by sex and age (< 65 vs. ≥65 years). Cause-specific and Fine-Gray models estimated hazard ratios for diabetes, hypertension, hypercholesterolemia, smoking, and body mass index.
Results
Diabetes and hypertension were the strongest predictors of CVD mortality across most subgroups. In the Fine-Gray model, diabetes showed the greatest impact in women < 65 years (HR: 4.83, p < 0.001), while hypertension showed the strongest association in women ≥ 65 years (HR: 3.32, p < 0.001). Hypercholesterolemia was associated with increased CVD mortality exclusively in women < 65 years (HR: 1.79, p = 0.02). Body mass index showed no significant association.
Conclusion
Diabetes and hypertension are the predominant risk factors for CVD mortality in the presence of competing risks, with effect magnitudes varying by sex and age. Applying competing risk models is essential for accurate risk estimation and targeted prevention in populations with high competing mortality burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Present Address: Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Biostatistics and Epidemiology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Biostatistics, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
ORCID-Profile: Masoumeh Mahdi-Akhgar, Ebrahim Hajizadeh, Ahmadreza Baghestani, Davood Khalili, Hamid Reza Khalkhali
Zitieren
APA
Mahdi-Akhgar, M., Hajizadeh, E., Baghestani, A., Khalili, D., & Khalkhali, H. R. (2026). Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study. Journal of Diabetes & Metabolic Disorders, 25(2). https://doi.org/10.1007/s40200-026-02010-6
Vancouver
Mahdi-Akhgar M, Hajizadeh E, Baghestani A, Khalili D, Khalkhali HR. Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study. Journal of Diabetes & Metabolic Disorders. 2026;25(2). doi:10.1007/s40200-026-02010-6
BibTeX
@article{MahdiAkhgar2026,
author = {Mahdi-Akhgar, Masoumeh and Hajizadeh, Ebrahim and Baghestani, Ahmadreza and Khalili, Davood and Khalkhali, Hamid Reza},
title = {Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study},
journal = {Journal of Diabetes & Metabolic Disorders},
year = {2026},
volume = {25},
number = {2},
doi = {10.1007/s40200-026-02010-6}
}
EUVIMED